TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).

Shinji Nakamichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.